XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Changes In Stockholders' Equity (Statement) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2019   39,251      
Beginning balance at Dec. 31, 2019 $ 114,601 $ 393 $ 251,641 $ (136,473) $ (960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 3,337     3,337  
Other comprehensive income (loss) (1,434)       (1,434)
Stock option exercises and employee stock plan purchases (in shares)   33      
Stock option exercises and employee stock plan purchases 366   366    
Vesting of restricted stock awards and units (in shares)   563      
Vesting of restricted stock awards and units 0 $ 6 (6)    
Shares withheld to cover taxes (in shares)   (97)      
Shares withheld to cover taxes (1,547) $ (1) (1,546)    
Stock-based compensation 3,075   3,075    
Ending balance (in shares) at Mar. 31, 2020   39,750      
Ending balance at Mar. 31, 2020 118,398 $ 398 253,530 (133,136) (2,394)
Beginning balance (in shares) at Dec. 31, 2019   39,251      
Beginning balance at Dec. 31, 2019 114,601 $ 393 251,641 (136,473) (960)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (10,061)        
Other comprehensive income (loss) (1,550)        
Ending balance (in shares) at Sep. 30, 2020   66,850      
Ending balance at Sep. 30, 2020 513,579 $ 668 661,955 (146,534) (2,510)
Beginning balance (in shares) at Mar. 31, 2020   39,750      
Beginning balance at Mar. 31, 2020 118,398 $ 398 253,530 (133,136) (2,394)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (7,012)     (7,012)  
Other comprehensive income (loss) (212)       (212)
Stock option exercises and employee stock plan purchases (in shares)   7      
Stock option exercises and employee stock plan purchases 50   50    
Vesting of restricted stock awards and units (in shares)   242      
Vesting of restricted stock awards and units 0 $ 2 (2)    
Shares withheld to cover taxes (in shares)   (36)      
Shares withheld to cover taxes (485) $ (1) (484)    
Issuance of common stock (in shares)   26,845      
Issuance of common stock, net of $3,776 issuance costs 394,334 $ 269 394,065    
Fair value of replacement options related to pre-acquisition services 7,125   7,125    
Stock-based compensation 3,385   3,385    
Ending balance (in shares) at Jun. 30, 2020   66,808      
Ending balance at Jun. 30, 2020 515,583 $ 668 657,669 (140,148) (2,606)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (6,386)     (6,386)  
Other comprehensive income (loss) 96       96
Stock option exercises and employee stock plan purchases (in shares)   32      
Stock option exercises and employee stock plan purchases 344   344    
Vesting of restricted stock awards and units (in shares)   13      
Vesting of restricted stock awards and units 0 $ 1 (1)    
Shares withheld to cover taxes (in shares)   (3)      
Shares withheld to cover taxes (50) $ (1) (49)    
Stock-based compensation 3,992   3,992    
Ending balance (in shares) at Sep. 30, 2020   66,850      
Ending balance at Sep. 30, 2020 513,579 $ 668 661,955 (146,534) (2,510)
Beginning balance (in shares) at Dec. 31, 2020   66,875      
Beginning balance at Dec. 31, 2020 514,205 $ 669 665,530 (149,946) (2,048)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 9,008     9,008  
Other comprehensive income (loss) 808       808
Stock option exercises and employee stock plan purchases (in shares)   155      
Stock option exercises and employee stock plan purchases 2,380 $ 1 2,379    
Vesting of restricted stock awards and units (in shares)   489      
Vesting of restricted stock awards and units 0 $ 5 (5)    
Shares withheld to cover taxes (in shares)   (85)      
Shares withheld to cover taxes (1,599) $ (1) (1,598)    
Stock-based compensation 3,317   3,317    
Ending balance (in shares) at Mar. 31, 2021   67,434      
Ending balance at Mar. 31, 2021 528,119 $ 674 669,623 (140,938) (1,240)
Beginning balance (in shares) at Dec. 31, 2020   66,875      
Beginning balance at Dec. 31, 2020 514,205 $ 669 665,530 (149,946) (2,048)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (31,064)        
Other comprehensive income (loss) 906        
Ending balance (in shares) at Sep. 30, 2021   67,659      
Ending balance at Sep. 30, 2021 499,344 $ 677 680,819 (181,010) (1,142)
Beginning balance (in shares) at Mar. 31, 2021   67,434      
Beginning balance at Mar. 31, 2021 528,119 $ 674 669,623 (140,938) (1,240)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (26,657)     (26,657)  
Other comprehensive income (loss) 240       240
Stock option exercises and employee stock plan purchases (in shares)   116      
Stock option exercises and employee stock plan purchases 2,043 $ 1 2,042    
Vesting of restricted stock awards and units (in shares)   51      
Vesting of restricted stock awards and units 0 $ 1 (1)    
Shares withheld to cover taxes (in shares)   (9)      
Shares withheld to cover taxes (193)   (193)    
Stock-based compensation 4,588   4,588    
Ending balance (in shares) at Jun. 30, 2021   67,592      
Ending balance at Jun. 30, 2021 508,140 $ 676 676,059 (167,595) (1,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (13,415)     (13,415)  
Other comprehensive income (loss) (142)       (142)
Stock option exercises and employee stock plan purchases (in shares)   48      
Stock option exercises and employee stock plan purchases 961 $ 1 960    
Vesting of restricted stock awards and units (in shares)   23      
Shares withheld to cover taxes (in shares)   (4)      
Shares withheld to cover taxes (67)   (67)    
Stock-based compensation 3,867   3,867    
Ending balance (in shares) at Sep. 30, 2021   67,659      
Ending balance at Sep. 30, 2021 $ 499,344 $ 677 $ 680,819 $ (181,010) $ (1,142)